Antibody-mediated xenograft injury: mechanisms and protective strategies
- PMID: 19376229
- PMCID: PMC2695451
- DOI: 10.1016/j.trim.2009.03.008
Antibody-mediated xenograft injury: mechanisms and protective strategies
Abstract
The use of porcine organs for clinical transplantation is a promising potential solution to the shortage of human organs. Preformed anti-pig antibody is the primary cause of hyperacute rejection, while elicited antibody can contribute to subsequent "delayed" xenograft rejection. This article will review recent progress to overcome antibody mediated xenograft rejection, through modification of the host immunity and use of genetically engineered pig organs.
References
-
- Cooper DKC, Dorling A, Pierson RN, III, et al. α1,3-galactosyltransferase gene-knockout pigs: where do we go from here? Transplantation. 2007;84(1):1–7. - PubMed
-
- Platt JL, Bach FH. Mechanism of tissue injury in hyperacute xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, editors. Xeno-transplantation The transplantation of organs and tissues between species. Springer-Verlag; Berlin Heidelberg: 1991. pp. 69–79.
-
- Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, III, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation. 1991;52:214–220. - PubMed
-
- Wu G, Pfeiffer S, Schroder C, Zhang T, Nguyen BN, Kelishadi S, Atkinson JB, Schuurman HJ, White DJ, Azimzadeh AM, Pierson RN., III Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes. Xenotransplantation. 2007;14:34–47. - PubMed
-
- Rose AG, Cooper DK. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation. 2000;7(1):31–41. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
